Büke Celikdemir (Würzburg, Germany) - RB1 knockdown and the expression of BCL-2, EZHIP, constitutive AKT and L-MYC in SCC cell lines result in increased SOX2 expression, a spindle-shaped morphology and improved survival in low attachment plates

Sara Passerini (Rome, Italy) - Development of an in vitro pulmonary cell model to study Merkel Cell Polyomavirus molecular biology and oncogenic mechanisms involved in tumors other than Merkel Cell Carcinoma

Wen Xu (Brisbane, Australia) - Subcutaneous Merkel cell carcinoma – a case series

Wen Xu (Brisbane, Australia) - Population based Merkel cell carcinoma outcomes over 10 years in Queensland, Australia

Hao Shi (Stockholm, Sweden) - Dissecting the role of PD-L1 isoforms in Merkel cell carcinoma

Meng Luo (Essen, Germany) - Anti-tumoral effect of prohibitin ligands on Merkel cell carcinoma

Hannah Björn Andtback (Stockholm, Sweden) - Biomarkers predicting benefit of checkpoint inhibition in advanced Merkel cell carcinoma - A systematic review

Libuse Janska (Stockholm, Sweden) – Exploring the cell surface - expression and polarization of immune-related protein markers on Merkel cell carcinoma tumor cells and infiltrating immune cells

Yajie Yang (Stockholm, Sweden) - Identifying metastasis biomarkers in Merkel cell carcinoma

Julian Kött (Hamburg, Germany) - The Hamburg Merkel cell carcinoma cohort – Clinical analysis and retrospective evaluation